Metazym

Metazym is being trialed in Patients with late infantile Metachromatic Leukodystrophy[1]. The drug produced by Shire costs in the vicinity of US$90,000 per month [2]. A company spokesman notes that the drug will not be on the market until at least 2012

Notes

  1. http://clinicaltrials.gov/ct2/show/NCT00681811
  2. http://www.smh.com.au/world/sick-childs-parents-dump-175m-outside-drugs-firm-20090716-dlts.html
  • Currently 0.00/5

Rating: 0.0/5 (0 votes cast) login to rate

Add to Favorite Print This Page Publish on Twitter
Bookmark and Share
close about Number of comments per page:
Time format: relative absolute
You need JavaScript enabled for viewing comments